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Abstract: CD8+ T-cells are involved in controlling HIV-1 infection by eliminating infected cells and secreting soluble 
factors that inhibit viral replication. To investigate the mechanism and significance of infection of CD8+ T-cells by HIV-1 
in vitro, we examined the susceptibility of these cells and their subsets to infection. CD8+ T-cells supported greater levels 
of replication with T-cell tropic strains of HIV-1, though viral production was lower than that observed in CD4+ T-cells. 
CD8+ T-cell infection was found to be productive through ELISA, RT-PCR and flow cytometric analyses. In addition, the 
CD8+CD45RO+ memory T-cell population supported higher levels of HIV-1 replication than CD8+CD45RA+ naïve T-
cells. However, infection of CD8+CD45RO+ T-cells did not affect their proliferative response to the majority of mitogens 
tested. We conclude, with numerous lines of evidence detecting and measuring infection of CD8+ T-cells and their sub-
sets, that this cellular target and potential reservoir may be central to HIV-1 pathogenesis. 
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INTRODUCTION 
  The Human Immunodeficiency Virus (HIV)/Acquired 
Immune Deficiency Syndrome (AIDS) pandemic is of great 
concern to the global population and much effort and re-
search is necessary to understand and treat the viral disease. 
Currently, there are over 40 million people worldwide living 
with HIV/AIDS. HIV-1 is the etiologic agent that is respon-
sible for AIDS, which occurs during the latter stages of viral 
pathogenesis (approximately 8-10 years after the initial in-
fection). 
  A recent source of controversy exists over the nature of 
HIV-1 infection of CD8+ T-cells. CD8+ T-cells play a cru-
cial role in the cell-mediated response of the immune system 
as these cells are able to recognize and eliminate cells in-
fected with foreign pathogens through their Cytotoxic T-
lymphocyte (CTL) abilities [1]. In addition to their CTL 
abilities, the CD8+ T-cell Non-cytotoxic Antiviral Response 
(CNAR) can produce and secrete a number of soluble HIV-1 
inhibitory factors that can block intracellular viral replication 
in CD4+ T-cells and other cellular subsets [2]. While there is 
an early increase in the number and function of HIV-1 spe-
cific CTLs, it has been established that in chronic infection, 
the decline in the CD8+ T-cell response accompanies pro-
gression to symptomatic disease [3, 4]. The significance and 
importance of CD8+ T-cells in viraemic control was eluci-
dated in studies with Long-Term Non-Progressors (LTNP). 
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CD8+ T-cells from LTNPs of HIV-1 infection maintain 
normal CD8+ T-cell numbers, greater functionality and per-
sistent HIV-1 specific CTL responses than those of progres-
sors [4, 5]. 
  Although the central focus of HIV-1 pathogenesis has 
been on the role of CD4+ T-cells, there has been much re-
cent evidence demonstrating the susceptibility of CD8+ T-
cells to HIV-1 infection both in vivo and in vitro (reviewed 
in [1]). The cause of CD8+ T-cell dysfunction and depletion 
during HIV-1 infection in vivo still remains unclear. This 
phenomenon is generally attributed to the lack of CD4+ T-
cell help or to the secretion of soluble viral proteins in the 
viral milieu. It has been demonstrated that the presence of 
CD4+ T-cells and antigen presenting cells are critical in 
CD8+ T-cell maturation and function [6]. In addition, anti-
genic stimulation of CD8+ T-cells may result in a state of 
anergy and possibly cell death [7] inducing an accompani-
ment of chronic unresponsiveness in the immune system. 
Work done by Potter et al. and others have implicated CD8+ 
T-cells as a reservoir of circulating HIV-1 infected cells [8, 
9]. Direct infection of CD8+ T-cells may also explain the 
abnormalities and dysfunction seen in this subset during 
AIDS pathogenesis. Over the past couple of years, numerous 
mechanisms have been proposed to explain HIV-1 entry into 
CD8+ T-cells. One such mechanism involved the selection 
of CD8-tropic variants of HIV-1 that were syncytium induc-
ing and cytopathic for CD8+ T-cells [10, 11]. A few of these 
viral isolates from HIV-1 infected individuals were shown to 
be able to use the CD8 cell-surface molecule as a receptor 
[11]. Cell-to-cell transfer of viral particles has also been pos-
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cells [12, 13]. Lastly, a number of investigators have shown 
that the expression of the CD4 molecule on CD8+ T-cells 
increased subsequent to activation [14-18]. These aptly 
termed CD4
dimCD8
bright T-cells were found to be susceptible 
to HIV-1 infection. Key studies by Hughes et al. demon-
strated that virus derived from HIV-1 infected CD8+ T-cells 
accounted for approximately 15% of the plasma viral load in 
vivo [19]. 
  One of the hallmarks of the immune system is the ability 
to generate memory. This defining aspect of the immune 
response is critical in controlling and recognizing viral infec-
tions. In response to an infection, CD8+ T-cells differentiate. 
Upon antigen recognition through Major Histocompatibility 
Complex (MHC)-I molecules, naïve CD8+ T-cells (CD8+ 
CD45RA+CD28+CCR7+) become activated and differenti-
ate into memory (CD8+CD45RO+CD28+CD27+CCR7+) 
and effector (CD8+CD45RA+CD28-CD27-CCR7-) T-cells 
[20]. Once the immune response subsides and the infection is 
cleared, the majority of the activated CD8+ T-cells are 
eliminated, but a few remain circulating in the immune sys-
tem. These circulating cells exist as memory cells that are 
pathogen-specific [21]. In addition, the memory CD8+ T-
cells are able to circulate for extended periods of time be-
cause of high levels of anti-apoptotic molecules [22] and, 
unlike naïve CD8+ T-cells, they are able to proliferate in the 
absence of antigen in vivo [23]. 
  Impairment of the function and activities of CD8+ T-
cells could allow the virus to escape from immune contain-
ment and further contribute to the deterioration of the in-
fected individual’s health. Early studies examining the ef-
fects of HIV-1 infection of CD8+ T-cells noted that infection 
was minimal in vivo. However, these studies did not use very 
sensitive techniques to detect HIV-1 infection and the asso-
ciated effects. More recent studies using sensitive quantita-
tive RT-PCR and flow cytometry have demonstrated fre-
quent infection of CD8+ T-cells. To investigate the suscepti-
bility of CD8+ T-cells to HIV-1 infection in vitro and the 
functional significance of infection, we examined levels of 
HIV-1 replication and the effects of viral infection in CD8+ 
T-cells and T-cell subsets. The susceptibility of CD8+ T-
cells to T-cell tropic and macrophage tropic strains of HIV-1 
was also analyzed. In addition, we determined the frequency 
of HIV-1 infection in the CD8+ T-cell population as meas-
ured by an intracellular HIV-1 assay. Lastly, we examined 
the effects of HIV-1 infection on CD8+ T-cell subsets. We 
hypothesized that CD8+ T-cells would be able to support 
productive HIV-1 replication and may serve a role as a cellu-
lar reservoir for HIV-1 production and replication. From our 
results, we observed that CD8+ T-cells were able to support 
productive infection with T-cell tropic viral strains inde-
pendent of CD4 cell-surface expression. Interestingly, HIV-1 
replicated preferentially in the CD8+ T-cell memory subset, 
resulting in an increase in the activation state of these cells. 
However, the infection-induced activation did not alter the 
ability of the memory T-cells to proliferate in response to the 
majority of mitogens used for stimulation. The identification 
of a potential novel cellular target and reservoir may have a 
profound effect on our views of HIV-1 disease progression 
and treatment. 
MATERIALS AND METHODOLOGY 
Isolation of Lymphocyte Populations 
  Blood samples from healthy volunteers were collected 
into tubes containing Ethylenediamine Tetra-acetic Acid 
(EDTA) by venipuncture. Samples were diluted with an 
equal volume of Phosphate Buffered Saline (PBS) and Pe-
ripheral Blood Mononuclear Cells (PBMCs) were isolated 
by Ficoll-Hypaque (Amersham Biosciences, Baie d’Urfe, 
PQ) density centrifugation. Subsequent to density centrifuga-
tion, isolated PBMCs were washed twice in PBS. CD8+ and 
CD4+ T-cell populations were isolated from freshly purified 
PBMCs through positive selection using anti-CD8 and -CD4 
conjugated magnetic beads (Miltenyi, Auburn, CA) respec-
tively, according to the manufacturer’s protocol. Briefly, 
cells were labeled with the magnetically conjugated antibody 
of interest for 20 minutes at 4ºC. Subsequent to labeling, 
cells were placed through a column inserted in the magnetic 
field of a MACS separator (Miltenyi) and unbound cells 
were washed with MACS buffer (PBS, 0.5% Bovine Serum 
Albumin (BSA), 2 mM EDTA, pH 7.2). After washing un-
bound cells, the column was removed from the separator and 
the labeled cells were eluted with the addition of MACS 
buffer. Following elution, the isolated T-cell subsets were 
washed twice with PBS. 
  The isolation of CD8+ T-cell subsets was performed us-
ing anti-CD8 Multisort conjugated magnetic beads 
(Miltenyi). In order to isolate the T-cell subsets, a second 
round of positive selection with magnetic bead-conjugated 
antibodies to either CD45RO+ or CD45RA+ was performed. 
Similarly, CD28, CD38 and HLA-DR positive and negative 
populations were selected using the Multisort conjugated 
magnetic beads. 
Cell Culture 
  PBMCs and T-cell subsets were cultured in RPMI-10 
(RPMI 1640 medium supplemented with 10% Fetal Calf 
Serum (FCS), 100 U/mL penicillin (Invitrogen, Burlington, 
ON), 100 μg/mL streptomycin (Invitrogen), and 20 U/mL 
Interleukin (IL)-2 (Sigma-Aldrich, St. Louis, MO)). Cells 
were incubated at 37°C with 5% CO2. 
Sources of Viruses 
  The T-cell tropic laboratory strain HIVIIIB was obtained 
from Advanced Biotechnologies Incorporated (Columbia, 
MD). The macrophage tropic laboratory strain, HIVADA, was 
obtained from the National Institutes of Health (NIH) AIDS 
Research and Reference Reagent Program (Germantown, 
MD). The clinical isolates of HIV-1 were generated from the 
blood of HIV-1 infected individuals. Briefly, PBMCs were 
isolated from the peripheral blood of infected subjects by 
Ficoll-Hypaque density centrifugation. The CD8+ T-cell 
fraction was removed from the isolated PBMCs through the 
use of anti-CD8 conjugated magnetic microbeads. The re-
maining cells were subsequently cultured with HIV-negative 
PHA blastocytes in RPMI-10. The cultures were monitored 
at days 10 and 15 for HIV-1 p24 production by an Enzyme-
Linked Immunosorbent Assay (ELISA) (SAIC-Frederick 
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  The titre of the viral stock was determined by a TCID50 
assay. Briefly, 100 L serial dilutions of the viral stock (ap-
proximately 1,500 ng/mL as determined by a HIV-1 p24 
ELISA) was used to infect 250,000 MT2 cells (American 
Type Culture Collection (ATCC), Manassas, VA) in quadru-
plicate in a 96-well flat bottom plate. Subsequent monitoring 
for the formation of syncytia was performed over a 7-day 
culture period. The titre of the viral stock was determined by 
the Reed-Muench accumulative method. The titre of the 
HIVIIIB viral stock used for CD8+ T-cell infections was 
found to be 1 x 10
5. Unless otherwise noted, 300 TCID50/mL 
of the viral inoculum for each of the viral isolates was used 
to infect isolated cells at a density of 1 x 10
6 cells/mL during 
the course of the in vitro experiments. 
HIV-1 Infection and Monitoring of Replication in CD8+ 
T-Cell Populations 
  Immediately after isolation and prior to infection, CD8+ 
T-cells were stimulated with 2.5 μg/mL of Phytohemaggluti-
nin (PHA) (Sigma-Aldrich) for three hours followed by sub-
sequent washes and a 1 hour incubation with 2 μg/mL poly-
brene (Sigma-Aldrich) in RPMI-10. Subsequently, the cells 
were washed, re-cultured in RPMI-10 and infected with 300 
TCID50/mL of the appropriate viral strains and isolates. 
Three days after the infection, the cells were extensively 
washed to remove any extracellular virus and debris and 
were re-cultured in RPMI-10 and this time point was consid-
ered the zero time point in the infection assays. In order to 
determine the levels of HIV-1 replication and production, 
cell-free supernatants were taken at days 5, 10 and 15 (or as 
indicated in the results and figures) post-infection from the 
infected cell cultures. Virus replication was assessed by 
HIV-1 production as measured by an ELISA (SAIC-
Frederick Inc.). In order to normalize our results, super-
natants were taken from cultures of CD8+ T-cells derived 
from several different individuals. 
  In order to assess productive infection, the reverse tran-
scriptase inhibitor, Azidothymidine (AZT) (NIH AIDS Re-
search and Reference Reagent Program) was used to treat the 
cells at a concentration of 10 μM for one hour prior to infec-
tion and was not used further throughout the time course. 
Nucleic Acid Extraction and Detection of Productive 
HIV-1 Infection by RT-PCR Analysis 
  Total RNA was isolated from 3 x 10
6 cells using the 
GeneElute Mammalian Total RNA Miniprep Kit (Sigma-
Aldrich). First strand cDNA was reverse transcribed with a 
pd(N)6 primer and Moloney Murine Leukaemia Virus 
(MMLV) reverse transcriptase using the First-Strand cDNA 
synthesis kit (Amersham Biosciences) according to the 
manufacturer’s protocol. RT-PCR reactions were set up for 
each cDNA towards the gag region of HIV-1 (p24 forward: 
5’-ATAGAGGAAGAGCAAAACAAAA-3’; p24 reverse: 
5’-CAAAATTACCCTATAGTGCA-3’). Each reaction was 
conducted in a total volume of 25 L containing 2.5 L of 2 
mM dNTP (Amersham Biosciences), 1.25 L of 50 mM 
MgCl2 (Amersham Biosciences), 1 L of each primer (from 
a 100 mM stock) and 1 U of Taq DNA polymerase (Amer-
sham Biosciences). A total of 5 L of each cDNA was used 
in the RT-PCR analysis. RT-PCR amplification was per-
formed for 35 cycles of: denaturing at 94ºC for 60 seconds, 
annealing at 55ºC for 60 seconds and extension at 72ºC for 
60 seconds. This was followed by a final extension for 10 
minutes at 72ºC. RT-PCR amplicons were run at 80 V on a 
1% agarose gel containing 0.5 g/mL of ethidium bromide 
and visualized under Ultraviolet (UV) light. 
Flow Cytometric Analysis 
  Flow cytometric analysis was gated on the live cell popu-
lations. Measurement of the levels of intracellular HIV-1 
staining was performed as follows: 1 x 10
6 cells were perme-
abilized with the Fix & Perm cell permeabilization kit (Cal-
tag Laboratories, Burlingame, CA) according to the manu-
facturer’s protocol. Cells were labeled with 10 L of the 
appropriate fluorochrome-conjugated monoclonal antibodies 
CD8-PC5 (Serotec, Raleigh, NC), CD4-PC5 (Serotec) and 
HIV-1gag-FITC (Coulter clone KC57, Beckman Coulter, 
Fullerton, CA) prior to flow cytometry analysis. The KC57 
antibody identifies HIV-1 core antigens (p55, p39, p33 and 
p24). Results were assessed on an Epics ALTRA  system 
(Beckman Coulter) after gating on lymphocytes based on 
their forward and side scatter properties. Analysis was per-
formed using Expo32 software (Applied Cytometry Systems, 
Sacramento, CA) and was based on a minimum of 10, 000 
events. Values are expressed as the mean fluorescence inten-
sity. 
  For the analysis of the purity of the isolated populations 
of CD8+ T-cells, the following fluorochrome-conjugated 
monoclonal antibodies were used: CD8-PE (Serotec), CD4-
FITC (Serotec), CXCR4-PE (BD Biosciences, San Diego, 
CA), CCR5-PE (BD Biosciences), IgG-FITC (BD Bio-
sciences), CD3-FITC (BD Biosciences), CD56/16-PE (BD 
Biosciences). For flow cytometric analysis, the cells of inter-
est were washed twice in PBS and once in flow binding 
buffer (PBS, 0.1% NaN3, 2% BSA). The cells were subse-
quently resuspended at a concentration of 1 x 10
6 cells per 
100 μL of flow resuspension buffer and were labeled with 10 
μL of the appropriate antibody for 30 minutes at room tem-
perature. Prior to flow cytometric analysis, the cells were 
fixed in 200 μL of PBS/4% paraformaldehyde at 4ºC for 5 
minutes. Cell-surface molecule expression during the course 
of HIV-1 infection was examined in positively selected cells 
using CD8-PE (Serotec), CD4-FITC (Serotec), CXCR4-PE 
(BD Biosciences), CCR5-PE (BD Biosciences), CD45RA-
PE (BD Biosciences),  CD45RO-FITC (Immunotech, 
Fullerton, CA), CD28-FITC (BD Biosciences), CD38-FITC 
(BD Biosciences) and HLA-DR-FITC (BD Biosciences) 
conjugated monoclonal antibodies. In order to determine the 
surface expression of both CD45RA and CD45RO in the 
CD8+CD4- and CD8+CD4+ populations, cells were exam-
ined by flow cytometry at day 5 post-infection after staining 
with antibodies directly conjugated to FITC. 
Lymphocyte Proliferation Assay 
  Lymphocyte proliferation was measured by the XTT 
based colorimetric assay (Roche Laboratories, Meylan, 
France). In the memory CD8+ T-cell studies, 
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PBMCs of a healthy volunteer by magnetic labeling. Cells 
were either left uninfected or infected with 300 TCID50/mL 
of HIVIIIB. For proliferation tests, approximately 450,000 
cells were seeded in triplicate in 100 μL of culture medium 
(RPMI-10 supplemented with 20 U/mL of IL-2) per well of a 
96-well flat bottom plate. Cells were incubated in the pres-
ence of each of the following mitogens: 3 g/mL 
CD3/CD28 (Sigma-Aldrich); 10 ng/mL Phorbol Myristate 
Acetate (PMA) (Sigma-Aldrich); 2 U/mL Tetanus Toxoid 
(TT) (Sigma-Aldrich); and 5 g/mL PHA. On days 2-3 post-
mitogenic stimulation, cells were labeled with 50 μL of the 
XTT labeling reagent as per the manufacturer’s protocol. 
The proliferation index was assessed by measuring the ab-
sorbance at 492 nm (with a reference wavelength at 690 nm) 
18 hours post-labeling. 
Statistical Analysis 
  Data are expressed as the mean ± SEM. Differences in 
measured
 variables between experimental and control groups 
were assessed
 using the Student’s t test. Statistical signifi-
cance was accepted
 at p < 0.05.
 
RESULTS 
Susceptibility of Primary Blood-Derived CD8+ T-Cells to 
HIV-1 Infection In Vitro 
  After establishing the purity of the selected CD8+ T-cell 
population and demonstrating the absence of any contami-
nating CD4+ T-cells or Natural Killer (NK) cells (data not 
shown), the ability of CD8+ T-cells to support HIV-1 infec-
tion was ascertained. In vitro infection of primary CD8+ T-
cells was performed with T-cell and macrophage tropic 
strains of HIV-1, along with Non-Syncytia Inducing (NSI) 
and Syncytia Inducing (SI) clinical isolates of the virus. The 
CD8+ T-cells were infected with an equal amount of virus, 
allowing the infection sensitivity of the CD8+ T-cells for the 
viral isolates and strains to be compared. Fig. (1A) shows a 
15 day time course of virus replication of the two laboratory 
strains and the two clinical isolates of HIV-1 in positively 
selected CD8+ T-cells. As measured by a HIV-1 p24 ELISA, 
the T-cell tropic strain, HIVIIIB, maintained the highest levels 
of viral production in the CD8+ T-cell population and the 
levels of virus replication for the HIVIIIB  strain reached a 
peak at day 15 post-infection (Fig. 1A). The replication of 
the T-cell tropic clinical isolate was also supported in CD8+ 
T-cells, although to lower levels than the laboratory strain. 
Similarly, CD8+ T-cells also supported moderate levels of 
replication of the macrophage tropic laboratory strain, 
HIVADA, but replication of the macrophage tropic clinical 
isolate was poor. 
  In contrast to the viral kinetics of the T-cell and macro-
phage tropic laboratory strains and the T-cell tropic clinical 
isolate, the levels of HIV-1 production for the macrophage 
tropic clinical isolate declined over the 15 day time course. 
Input virus was not the cause of the low levels of viral pro-
duction observed by this clinical isolate as CD8+ T-cells 
were extensively washed 3 days post-infection and day 0 of 
the infection assay was denoted at this point. Based on the 
above results, the HIVIIIB strain was used in subsequent ex-
periments due to the ability of CD8+ T-cells to support high 
levels of replication of this virus. 
  Most HIV-1 strains require CXCR4 or CCR5 as a co-
receptor for viral entry, along with CD4 expression. The 
surface expression of the chemokine receptors on primary 
CD8+ T-cells was examined by flow cytometry. It was ob-
served that the CXCR4 chemokine receptor was significantly 
expressed on the surface of the CD8+ T-cells (55.9% ± 2.1, 
Fig. 1B). The expression of the CCR5 chemokine receptor 
was only moderately expressed on the CD8+ T-cell-surface 
(11.6% ± 1.0, Fig. 1C). Comparison of viral replication ki-
netics was assessed between CD8+ and CD4+ T-cells over a 
15 day time course (Fig. 1D). CD8+ T-cells were found to 
support approximately 10-fold lower levels of HIV-1 repli-
cation than CD4+ T-cells in vitro. Fig. (1D & 1A) illustrate 
differences in CD8+ T-cell infection and replication kinetics 
of viral production. A caveat of in vitro infection is the ob-
servation of these variances due to differences in CD8+ T-
cell populations used for the studies and the requirement for 
cell culture activation through cytokines/antigens for produc-
tive infection. 
  Productive infection was demonstrated by RT-PCR 
analysis. Only HIV-1 infected CD8+ and CD4+ T-cells, 
showed that viral infection was productive as both T-cell 
populations showed a HIV-1 gag-specific band when RT-
PCR analysis was performed (Fig. 2A). Productive infection 
was also demonstrated in Fig. (2B) where the presence of 
AZT abrogated HIV-1 replication in CD8+ T-cells isolated 
from two volunteers. Differences in the levels of viral pro-
duction were also observed between the two subjects. Sub-
ject 2 supported lower levels of HIV-1 production in their 
isolated CD8+ T-cells in the absence of AZT, indicating dif-
ferences in viral replication supported by CD8+ T-cells from 
various individuals. 
  To further determine whether CD8+ T-cells could sup-
port HIV-1 infection, flow cytometry was performed to de-
tect the presence of HIV-1 p24 (HIV-1gag) intracellularly in 
this population. As shown in Fig. (3A, circle, upper right 
quadrant), 6.5% of the total CD8+ T-cell population were 
infected intracellularly with HIV-1gag. As a control for the 
experiment, the contribution of CD8+CD4+ cells to the 6.5% 
of total infected cells was determined. The isolated and in-
fected CD8+ T-cells were stained additionally with a CD4 
antibody and intracellular HIV-1 expression was again 
measured by flow cytometry (Fig. 3B). From the results, 
approximately 1.6% of the CD8+CD4+ cells contributed to 
the total levels of the CD8+ T-cell infection obtained in Fig. 
(3A). They did not contribute significantly to the total levels 
of infection due to the low mean fluorescence intensity of 
this population. Two distinct populations of CD8+ T-cells 
were observed in the flow cytometric analysis based upon 
the expression levels of the CD8 molecule. These popula-
tions, that have been observed by others, differ in their sur-
face expression of the CD8 cell-surface molecule and have 
been aptly termed CD8
high and CD8
low expressing popula-
tions [24, 25]. A similar experiment illustrated that approxi-
mately 20 - 25% of CD4+ T-cells stained intracellularly for 
HIV-1 (data not shown). Infection of CD8+CD45RO+ Memory T-Cells by HIV-1  The Open AIDS Journal, 2008, Volume 2    47 
 
Fig. (1). Infection of CD8+ T-cells by HIV-1. (A) Selected CD8+ T-cells were infected with 300 TCID50/mL of the T-cell tropic and macro-
phage tropic laboratory strains and clinical isolates of HIV-1. HIV-1 p24 production was measured by an ELISA at the indicated time points 
with cell-free supernatants from cultures. Results show the mean HIV-1 production and SEM of three independent experiments. (B) CXCR4 
receptor expression on CD8+ T-cells as measured by flow cytometry. One representative of three experiments is shown. The mean fluores-
cence intensity of CXCR4 receptor and SEM of three independent experiments is 55.9% ± 2.1. (C) CCR5 receptor expression on CD8+ T-
cells. One representative of three experiments is shown. The mean fluorescence intensity of CCR5 receptor and SEM of three independent 
experiments is 11.6 ± 1.0. CD8+ T-cells were also stained with negative controls (isotype control, dashed line). (D) Positively selected CD4+ 
and CD8+ T-cells were infected with 300 TCID50/mL of HIVIIIB. HIV-1 production was measured by an ELISA at the indicated time points 
from cell-free supernatants. 
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Expression of the CD4 Cell-Surface Molecule on the Sur-
face of CD8+ T-Cells During HIV-1 Infection 
  To examine the possibility of CD4 up-regulation in the in 
vitro infection system used throughout the studies, CD8+ T-
cells were infected and monitored for CD4 expression by 
flow cytometry over a 12 day time course (Fig. 4). Interpre-
tation of the flow cytometry data showed very distinct popu-
lations. Analysis of both the uninfected and infected CD8+ 
T-cell populations showed that CD4 expression on these 
cells reached a maximum of 0.4% and 0.5%, respectively, on 
day 12 of culture. This suggests that cell culture conditions, 
not HIV-1 infection per se, resulted in this observed up-
regulation of CD4 on the surface of CD8+ T-cells. The over-
all majority of CD8+ T-cells were of the single-positive phe-
notype and the contribution of Double Positive (DP) cells 
was found to be minimal. 
Memory CD8+ T-Cells Support Higher Levels of HIV-1 
Replication 
  Subsets of CD8+ T-cells have been shown to be signifi-
cant in the control of HIV-1 infection and disease progres-
sion. It has been postulated that higher levels of CD8+   
 
 
Fig. (2). Productive HIV-1 infection of CD8+ T-cells in vitro. (A) RT-PCR analysis of HIV-gag transcripts in the uninfected and infected 
populations of isolated CD4+ and CD8+ T-cells. Isolated lymphocyte populations were left uninfected or infected with 300 TCID50/mL of 
HIVIIIB for 7 days prior to RT-PCR analysis. Detection of -actin was run as a loading control. Parallel samples were run without reverse 
transcriptase as a control for DNA contamination of the samples (data not shown). (B) Infection of CD8+ T-cells is sensitive to AZT. Infec-
tion was performed in the absence and presence of AZT and HIV-1 production was measured by an ELISA for the HIV-1 gag protein, p24. 
Cells were treated with 10 M of AZT for one hour prior to infection. CD8+ T-cells from two uninfected individuals were infected with 300 
TCID50/mL of HIVIIIB laboratory strain. The results shown are the mean and SEM of three independent experiments. Infection of CD8+CD45RO+ Memory T-Cells by HIV-1  The Open AIDS Journal, 2008, Volume 2    49 
 
CD38+ T-cells may be associated with poor prognosis and 
were found to be elevated in individuals who have progressed 
to AIDS [26, 27]. In contrast, high levels of CD8+HLA-DR+ 
cells were observed in asymptomatic individuals [28]. In stud-
ies with CD8+ CTLs, HLA-DR expression was found to cor-
relate with proliferation and CD28 expression [29]. Based on 
the possibility that HIV-1 infection may be involved in hinder-
ing the function and activities of various key CD8+ T-cell 
subsets, the susceptibility of the aforementioned subsets to in 
vitro HIV-1 infection was examined. Viral production was 
 
Fig. (3). Detection of intracellular HIV-1 expression in CD8+ T-cells. CD8+ T-cells were infected with 300 TCID50/mL of HIVIIIB or left 
uninfected. (A) Intracellular p24 was examined on the CD8+ T-cell population by flow cytometry at day 15 post-infection with antibodies to 
HIV-1gag (p24-RD1) and CD8. In the infected population, the number in the upper right quadrant represents the number of cells found in the 
circle as to minimize any false-positives. (B) To determine the contribution of CD4+ cells to in vitro CD8+ T-cell infection, intracellular 
HIV-1 expression was examined in the CD8+ T-cell population by flow cytometry at day 15 post-infection with antibodies to HIV-1gag and 
CD4 only. Numbers in the quadrants represent the percentage of gated cells in each quadrant. A minimum of 10, 000 events was assessed for 
each analysis. 
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measured in the CD8+ T-cell subset cultures over a 10 day 
time course by a HIV-1 p24 ELISA. The negative fractions 
obtained from the subset isolation were also assessed for HIV-
1 production. Interestingly, the CD8+CD28+, CD8+CD38+ 
and CD8+HLA-DR+ subsets all supported very low levels of 
HIV-1 replication (Fig. 5A). In fact, the levels of viral produc-
tion decreased over the course of in vitro infection in these 
subsets. Fig. (5A) also showed that 2.5 - 4 fold higher levels of 
replication were supported in the CD8+CD28-, CD8+CD38- 
and CD8+HLA-DR- populations, compared to the positive 
fractions. 
  Susceptibility of the memory and naïve CD8+ T-cell 
populations was also examined in response to HIV-1 infec-
tion with the HIVIIIB  strain. The CD8+CD45RA- and 
CD8+CD45RO+ memory cell populations both supported 
approximately 5 – 10 times higher levels of HIV-1 replica-
tion than the CD8+CD45RA+ and CD8+CD45RO- naïve 
populations (Fig. 6A). The p24 levels obtained in these ex-
periments were lower than the levels found in previous ex-
periments, as these infections were performed using lower 
levels of PHA stimulation to minimize any possible up-
regulation of receptors. We examined receptor expression 
during the course of infection (Fig. 6B) and confirmed by 
flow cytometry that there was no alteration in receptor ex-
pression during the course of in vitro infection within the 
memory and naïve CD8+ T-cell populations. 
 
Fig. (4). CD4 cell-surface molecule up-regulation on the surface of CD8+ T-cells. Uninfected and HIV-1 infected CD8+ T-cells were exam-
ined at the indicated time points by flow cytometry for the expression of the CD8 and CD4 cell-surface molecules. CD8+ T-cells were in-
fected with 300 TCID50/mL of HIVIIIB and cell-surface expression of CD8 and CD4 was assessed at days 3, 9 and 12 by flow cytometry. 
Numbers in the quadrants represent the percentage of gated cells in each quadrant. A minimum of 10, 000 events were assessed for each 
analysis. 
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Fig. (5). HIV-1 replication in CD8+ T-cell subsets. CD28, CD38 
and HLA-DR positive and negative populations were infected with 
HIV-1 and cultured. Cell-free supernatant samples were taken post-
infection at the indicated time points for measurements of HIV-1 
production by an ELISA. Results are the mean and SEM of three 
independent experiments.  
Proliferation of Memory CD8+ T-Cells in Response to 
HIV-1 Infection 
  HIV-1 infection has been reported to affect the frequency 
and function of circulating CD8+ T-cells, thereby hindering 
the ability of these cells to eradicate viral infection and main-
tain T-cell mediated immunity. In order to better define the 
effect of HIV-1 infection on the function and abilities of the 
CD8+ T-cell memory subset, CD8+CD45RO+ T-cell prolif-
eration in response to stimulation was measured. As assessed 
by flow cytometry and shown in Fig. (7A), the majority of 
the isolated CD8+ T-cells were of the naive subset (82.5% 
CD8+CD45RA+ naive T-cells; 14.5% CD8+CD45RO+ 
memory T-cells). The purity of our selected CD8+CD45RO+ 
memory T-cell population was also assessed. The selected 
memory T-cell population was devoid of any contaminating 
CD8+CD45RA+ naïve T-cells (Fig. 7B, right histogram) and 
was composed of approximately 97% pure cells of the 
CD8+CD45RO+ phenotype (Fig. 7B, left histogram). 
  Prior to mitogen stimulation, the CD8+CD45RO+ mem-
ory T-cells were infected (or left uninfected) for 7 days. Be-
fore measuring proliferation, the activation state of the 
memory cells was assessed before and after infection (Fig. 
7C). Based upon the flow cytometry results, the mean fluo-
rescence of CD28 expression nearly doubled (uninfected,   
 
 
Fig. (6). HIV-1 preferentially replicates in the CD8+CD45RO+ memory T-cells. (A) CD45RO positive and CD45RA positive populations 
were infected with 300 TCID50/mL of HIVIIIB and cultured. Supernatants were taken at days 5 and 10 post-infection for p24 measurement by 
ELISA. Results are representative of two independent experiments. (B) Uninfected () and infected () memory and naïve T-cells were ex-
amined for CD45RO, CD45RA, CD4 and CD8 receptor expression by flow cytometry at day 5 post-infection. 
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Fig. (7). Proliferative response of HIV-1 infected CD8+CD45RO+ memory T-cells in response to antigenic stimulation. (A) Positively se-
lected CD8+ T-cells were stained with CD45RO-FITC and CD45RA-PE to determine the percentage of memory cells in the isolated CD8+ 
T-cell population. (B) The purity of the selected CD8+CD45RO+ memory T-cells was assessed by flow cytometry and staining with 
CD45RO-FITC, CD45RA-PE (right histogram) and CD8-PE (left histogram). Numbers in the quadrants represent the percentage of gated 
cells in each quadrant. (C) Expression of the activation markers CD28, CD38 and HLA-DR in uninfected () and infected () 
CD8+CD45RO+ memory T-cells. Results are the mean percentage and SEM of three independent experiments as measured by flow cytome-
try. Statistical significance of p < 0.01 is denoted by an (*). (D) Lymphocyte proliferative ability of uninfected () and infected () 
CD8+CD45RO+ memory T-cells as measured by the XTT based colorimetric assay. Memory T-cells were infected (or left uninfected) for 7 
days prior to antigen stimulation. Cells were stimulated with CD3/CD28, Phytohemagglutinin (PHA), Phorbol Myristate Acetate (PMA), 
Tetanus Toxoid (TT) or left unstimulated (-). Proliferation was measured at days 2-3 post-antigenic stimulation by labeling with an XTT 
reagent during the last 18 hours of culture. Results are the mean and SEM of three independent experiments. Data is expressed as the mean 
absorbance (A492nm – A690nm) and SEM. 
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27.3% ± 0.3; infected, 52.3% ± 2.4) during the course of 
HIV-1 infection and this was found to be significant (p-value 
= 0.0026). There were marginal increases in CD38 and 
HLA-DR expression in response to infection. To determine 
the proliferative capacity of the memory subset, cells were 
stimulated for 2-3 days with various mitogens both in the 
presence and absence of HIV-1 infection. Based upon the 
results, it was found that minimal differences in in vitro 
lymphocyte proliferation between infected and uninfected 
CD8+CD45RO+ memory T-cells in response to mitogenic 
stimulation (Fig. 7D) were observed. Overall, HIV-1 infec-
tion resulted in a slightly reduced rate of proliferation in the 
CD8+CD45RO+ memory subset. Mitogenic stimulation with 
PHA resulted in a greater than 2-fold increase in prolifera-
tion in the uninfected memory T-cell population. However, 
the presence of PHA resulted in an approximately 30% re-
duction in the cleavage of XTT in the HIV-1 infected popu-
lation, indicating a decrease in proliferation. Conversely, 
CD3/CD28 stimulation resulted in a nearly 3-fold increase 
in the absorbance values in both the uninfected and infected 
CD8+CD45RO+ memory T-cell populations. 
DISCUSSION 
  Despite the accumulating research (and controversy) over 
the nature of HIV-1 infection of CD8+ T-cells, there is still a 
lack of information with regard to the effects of viral infec-
tion on CD8+ T-cells and their functions. Though previous 
studies have examined HIV-1 infection of CD8+ T-cells, 
these studies were limited predominantly to in vivo observa-
tions and did not have the availability of sensitive techniques 
used currently. Many of these studies also focused on the 
specific and secondary cytolytic abilities of CD8+ T-cells in 
response to infection and failed to examine or acknowledge 
the role that CD8+ T-cell subsets such as memory cells play 
in controlling not only HIV-1 infection, but other viral infec-
tions as well. Therefore, we set out to examine the suscepti-
bility of CD8+ T-cells and their subsets to in vitro HIV-1 
infection using standard laboratory strains in lieu of serially 
passaged isolates used in the past, and to examine the effects 
of infection on CD8+ T-cell function. 
  We observed that CD8+ T-cells were able to support vi-
ral infection and replication. To determine whether or not the 
infection was productive, we detected HIV-1 presence by 
RT-PCR analysis and treated the CD8+ T-cells with AZT, a 
viral replication inhibitor. We found infection to be produc-
tive as the presence of the reverse transcriptase inhibitor ab-
rogated HIV-1 production. Of interest was the observation 
that CD8+ T-cells supported higher levels of replication with 
T-cell tropic isolates and strains of HIV-1. Similarly, CD4+ 
T-cells also showed a preferential susceptibility to infection 
with T-cell tropic strains in vitro. An observation we found 
throughout our experiments were the differences in viral 
production and kinetics when CD8+ T-cells were isolated 
from numerous volunteers. This phenomenon is not re-
stricted solely to CD8+ T-cells as it is also apparent when 
CD4+ T-cells and macrophages of different individuals are 
infected in vitro [30]. Our results with T-cell tropic strains 
and isolates were expected as both CD4+ and CD8+ T-cells 
express high levels of the chemokine receptor CXCR4 that is 
predominantly used by the T-cell tropic HIV-1 strains for 
binding and entry. Specifically, the T-cell tropic laboratory 
strain HIVIIIB resulted in the greatest replication and produc-
tion in the isolated CD8+ T-cell population. Interestingly, the 
M-tropic laboratory strain, and to a significantly lesser extent 
the M-tropic clinical isolate, were also able to successfully 
infect CD8+ T-cells. This may be explained by the presence 
of moderate CCR5 expression on the surface of the CD8+ T-
cells. 
  Our experimental results have shown that CD8+ T-cells 
were able to support productive HIV-1 infection. Since the 
CXCR4 co-receptor was highly expressed on the surface of 
the CD8+ T-cells and the affinity of gp120 for the CD4 
molecule had already been established, we examined the 
possibility of CD4 up-regulation on the surface of CD8+ T-
cells during infection. Our results indicate that CD8+ T-cells 
supported approximately 10-fold lower levels of in vitro 
HIV-1 replication than what was routinely observed in CD4+ 
T-cells, corroborating a report that suggested that CD8+ T-
cells were low producers of HIV-1 [31]. A possible explana-
tion for this observation may be due to the low expression of 
the CD4 molecule on the surface of CD8+ T-cells and sub-
sequent down-regulation of this receptor following infection. 
In our experiments, increases in CD4 expression by CD8+ T-
cells over time in culture did not show a dependence upon 
infection and was not significantly observed in the in vitro 
HIV-1 infected CD8+ T-cell population. In addition, the con-
tribution of the CD8+CD4+ T-cells in the total CD8+ T-cell 
population during HIV-1 infection was less than 2%. Of note 
was the decrease in the mean fluorescence of the CD8 cell-
surface molecule in the infected population. This was most 
likely due to the cytopathic and anergizing effects of the cul-
turing of CD8+ T-cells in the presence of HIV-1 or the pos-
sible down-regulation of this molecule. 
 Brenchley  et al. observed that the number of HIV-1gag 
DNA copies in CD4
dimCD8
bright lymphocytes were 5 to 100 
fold more than in the CD8+CD4- lymphocytes [32]. How-
ever, the majority of cells that were infected with HIV-1 in 
our in vitro experiments were of the CD8+CD4- phenotype 
as measured by intracellular HIV-1gag staining. These find-
ings suggest the possibility of an alternate portal of entry that 
may be used by HIV-1 to enter CD8+CD4- T-cells. The role 
of the CD8 cell-surface molecule in HIV-1 infection cannot 
be discounted as recent evidence has shown that CD4-
independent HIV-1 variants exist in AIDS patients and these 
viruses preferentially infect CD8+ T-cells using CD8 as a 
receptor [10, 11]. 
  Levels of HIV-1 replication were examined in CD8+ T-
cells co-expressing CD28, CD38 or HLA-DR. These subsets 
were selected for study due to their significance in asymp-
tomatic infection and disease progression. From our results, 
we did not see an increase in susceptibility to HIV-1 infec-
tion in the CD28+, CD38+ or HLA-DR+ CD8+ T-cell sub-
sets. It may be argued that the observation that the positively 
selected populations were unable to support full HIV-1 repli-
cation was due to an inherent artifact present in the selection 
process with conjugated beads. However, when the memory 
and naïve subsets were examined later on, the positively se-54    The Open AIDS Journal, 2008, Volume 2  Gulzar et al. 
lected memory population resulted in the higher level of 
HIV-1 production, thereby discounting the notion that posi-
tive selection hindered susceptibility to infection. Interest-
ingly, these positively selected subsets showed a decrease in 
viral kinetics over time when compared to the negative frac-
tions. The decrease in replication kinetics may be due to the 
inability of these cells to support more than a minimal level 
of replication. Thus, without any suitable cellular target, the 
virus would eventually be unable to propagate. Of note are 
the levels of HIV-1 replication in the CD8+CD28- subset. 
The number of these cells increase early on and throughout 
the course of infection [33, 34], suggesting that the 
CD8+CD28- T-cells may be involved in the control of virus 
replication. If the CD8+CD28- cells are indeed involved in 
the suppression of HIV-1 replication and, based upon our 
observations, show an increase in susceptibility to HIV-1 
infection, then a key subset of CD8+ T-cells involved in 
fighting disease may be hampered or eliminated early on in 
the course of disease. 
  High levels of replication of HIV-1 were found in the 
CD8+CD45RO+ memory T-cell subset when compared to 
the CD8+CD45RA+ naïve T-cell subset. Both the 
CD8+CD45RO+ and CD8+CD45RA- memory T-cell popu-
lations showed significantly higher levels of replication than 
the CD8+CD45RO- and CD8+CD45RA+ naïve T-cell popu-
lations. However, previous research demonstrated that the 
CD8+CD45RA+ naïve subset was found to have a higher 
frequency of infection than the memory subset in vivo [35]. 
In addition, the naïve CD8+ T-cell population has also been 
shown to be the most susceptible to HIV-1 infection follow-
ing activation-induced up-regulation of the CD4 cell-surface 
molecule by antibodies to CD3 and CD28 [18]. While sus-
ceptibility to productive infection was observed in the 
CD8+CD45RA+ naïve T-cell subset in vitro, our results in-
dicate that HIV-1 replicated more efficiently and produc-
tively in the memory phenotype of CD8+ T-cells in the ab-
sence of activation-induced up-regulation of CD4 cell-
surface expression. In CD4+ T-cells, it has been documented 
that the CD45RO+ memory population serves as the main 
contributor to the pool of infected T-cells in vivo [36, 37]. 
The low level of HIV-1 replication in CD8+CD45RA+ naïve 
T-cells may be explained by the observation in CD4+ T-cell 
studies that infection of naïve CD4+ T-cells by laboratory 
isolates of HIV-1 results in insufficient T-cell activation that 
is required for the reverse transcription and integration of the 
viral genome [38-40]. These same observations may hold 
true for the infection of memory and naïve CD8+ T-cells in 
vitro reported here. Work done by Wills et al. may partly 
explain the high frequency of infection of CD8+CD45RA+ 
naïve T-cells in vivo. The researchers found that the 
CD8+CD45RA+ T-cells are not comprised solely of naïve T-
cells, but also contain a significant proportion of memory T-
cells that can change from a CD45RO
high to CD45RA
high 
phenotype in vivo [41]. Thus, during the course of HIV-1 
infection in vivo, the memory T-cell subset may play a role 
as the initial proviral reservoir, but may subsequently revert 
to the naïve T-cell phenotype that has been observed in re-
sponse to various stimuli. 
  In order to assess the effects of HIV-1 infection on 
CD8+CD45RO+ memory T-cells, we examined the ability of 
the infected memory cells to proliferate in response to in 
vitro HIV-1 infection. It has been postulated that T-cell dys-
function could be attributed to the altered sensitivity of 
CD8+ (and CD4+) T-cells to various co-stimulatory signals 
in HIV-1 infected patients. In vivo results have already dem-
onstrated the significant increase in memory T-cell numbers 
in acute viral infections [42, 43]. These experiments were 
performed in the absence of any CD4+ T-cell help. A long-
standing paradigm in immunology has been the requirement 
for CD4+ T-cell help in the expansion and maintenance of 
memory CD8+ T-cells in vivo [44, 45]. However, evidence 
has demonstrated that CD4+ T-cell help was not required for 
the proliferation and persistence of fully functional antigen-
specific memory CD8+ T-cells in the primary immune re-
sponse [46]. Our findings demonstrated that HIV-1 infection 
of the CD8+CD45RO+ memory T-cell subset did not impair 
the proliferative response of these cells to the majority of the 
mitogens used for stimulation which may be explained by 
the activation state of these cells. These results may partly be 
explained by the low levels of HIV infection seen in the 
CD8+ T-cell population (Fig. 3). If this assumption holds 
true, the majority of cells would be of the uninfected pheno-
type in the infected population. Therefore, no differences in 
proliferation may be due to the larger uninfected population 
functioning normally. Recently, Holm et al. demonstrated 
that HIV-1 virions induced CD8+ T-cells to up-regulate 
CD25 and HLA-DR and preferentially induced apoptosis in 
the CD8+CD25+HLA-DR+ T-cell subset [47]. Our isolated 
CD8+CD45RO+ T-cells also showed an up-regulation of 
HLA-DR during in vitro infection. However, our results also 
demonstrated that HIV-1 infection only minimally decreased 
proliferation in response to mitogenic stimulation when 
compared to the uninfected population. The lack of prolifera-
tion in the CD8+ memory T-cell population may be partly 
explained by the observations of Pantaleo et al. [48]. The 
researchers found that the CD8+HLA-DR+ subset was se-
verely defective in their proliferative response to anti-CD28, 
anti-CD3, anti-CD2, PHA and PMA. From our in vitro re-
sults, HIV-1 infection only resulted in a noticeable decrease 
in proliferation in the cells stimulated with PHA. Therefore, 
strong mitogenic stimulation with PHA in the presence of 
HIV-1 resulted in the decrease in proliferation. This may 
have led to the triggering of an apoptotic pathway or anergy 
in the infected CD8+CD45RO+ memory T-cell population 
by an aberrant form of T-cell activation induced by PHA 
stimulation. More importantly, naïve cells require stimula-
tion to proliferate and differentiate. Effector cells, on the 
other hand, are terminally differentiated and thus do not pro-
liferate. Therefore, a lack of proliferation in this subset 
would be expected. A limitation of our studies is the delinea-
tion of the memory and naïve subsets used in the studies. 
Future studies will examine the phenotype of these popula-
tions and assay CD8+ T-cell function by measuring CTL 
ability and cytokine expression profiles. 
 In  our  in vitro system, CD8+CD45RO+ memory T-cells 
only showed an impairment of their proliferative capacity in 
response to HIV-1 infection in the presence of PHA stimula-Infection of CD8+CD45RO+ Memory T-Cells by HIV-1  The Open AIDS Journal, 2008, Volume 2    55 
tion. The observation that memory T-cells serve as one of the 
main reservoirs for the virus has profound implications as a 
high proportion of the expanded CD8+ T-cell population in 
HIV-1 infected individuals is comprised of CD45RO+ cells 
[49]. These memory cells have an enhanced susceptibility to 
cell death [50] and die upon bystander activation [51]. In addi-
tion, the CD45RO+ phenotype contributes significantly to the 
HIV-specific CTL response and these CD45RO+ CTLs are 
preferentially lost upon disease progression [52]. The effect of 
infection on CD8+ T-cell CTL function, chemokine and cyto-
kine production, and the susceptibility to apoptosis could have 
a significant impact upon disease progression and our under-
standing of HIV-1 pathogenesis. The identification of a novel 
cellular target and viral reservoir will open up new avenues for 
treatment of this viral infection in the future. 
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